US private equity firm Carlyle has acquired a majority stake in two healthcare revenue cycle management (RCM) platforms: Knack RCM and EqualizeRCM. The investment is being made through Carlyle Asia Partners VI and Carlyle Asia Partners Growth II.
The sale process for Filipino hospital chain Metro Pacific Hospital Group has stalled due to price misalignment. US private equity firm KKR and Singaporean sovereign wealth fund GIC haven't managed to sell their joint 80% stake at the $3 billion + valuation they were targeting in 2024. The two main interested parties, US private equity firms TPG and Blackstone, think the roughly 20x multiple is far too high. HBI hears one of the bids came in as low as $2 billion.
Indian dialysis chain NephroPlus is to become a listed company. The group has filed a draft red herring prospectus with India’s capital markets regulatory body, the Securities and Exchange Board of India.
We’re about to release a Special Report on healthcare investment in Asia. The report offers a comprehensive overview of the dynamics, trends and opportunities in the healthcare markets of eight hugely important countries in the region: China, India, South Korea, Thailand, Vietnam, Indonesia, Malaysia and the Philippines.
In this HBI News Round Up we cover Hallo Healthcare Group’s exit from the healthcare services sector, Genesis MedTech’s sale of its subsidiary, JC Medical Inc to Edwards Lifesciences, biopharmaceutical company, Vertex Pharmaceuticals obtaining of a licence for CASGEVY in the UK, disease risk detection and preventative health company, Nightingale Health’s attaining of UK Conformity […]
CVC Capital Partners, a Luxembourg-based private equity firm, has acquired an additional 45% stake in Indonesia's chain of multi speciality hospitals, Siloam Hospitals, from the country’s conglomerate Lippo Karawaci for 16.6 trillion rupiah ($1 billion), making CVC the majority shareholder. This transaction, involving 5.85 billion shares, was announced on the Indonesia Stock Exchange.
Fullerton Health Corporation Limited (Fullerton Health), a multinational occupational health care provider in the Asia-Pacific region, confirmed on Tuesday that pharmaceutical company Far East Drug (B.V.I.) Co. Ltd (FED) is acquiring a significant stake in the Singapore-headquartered group.
Indian dialysis group NephroPlus has solidified its position in the Philippines with the acquisition of Renal Therapy Solutions, a six-clinic provider.
Singapore-based private equity firm Quadria Capital is set to inject $1.5bn worth of healthcare investments into South and South East Asian countries over the next two to three years. In line with growing trends, India stands to win big, earmarked to receive roughly 50% of the investment.
A shortage of high-quality healthcare workers in Europe is causing countries to recruit from a more global pool. The Danish government is partnering with India and the Philippines, and HBI hears LATAM could be the new hotspot from which foreign workers will be enlisted in future.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.